ERIK OATMAN: Open Payments
NPI 1639755754 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,954 in 94 payments from 31 companies in 2025. Trend: 2023 $13 · 2024 $1,425 · 2025 $1,954
Food & beverage: $1,954
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 10 | $238 |
| AstraZeneca Pharmaceuticals LP | 12 | $208 |
| Janssen Biotech, Inc. | 6 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $157 |
| Exact Sciences Corporation | 6 | $146 |
| Amgen Inc. | 9 | $144 |
| Merck Sharp & Dohme LLC | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Radius Health, Inc. | 3 | $72 |
| Lilly USA, LLC | 3 | $61 |
Products named: TREMFYA, Kerendia, SAPHNELO, Cologuard Collection Kit, RUKOBIA, APRETUDE, EVENITY, PIFELTRO.
Industry payments across NY — which companies pay providers there.
